Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides

Details for Australian Patent Application No. 2006308399 (hide)

Owner Topigen Pharmaceuticals Inc.

Inventors Damha, Masad; Ferrari, Nicolay

Agent Callinan

Pub. Number AU-A-2006308399

PCT Pub. Number WO2007/048244

Priority 60/741,544 02.12.05 US; 60/730,876 28.10.05 US

Filing date 26 October 2006

Wipo publication date 3 May 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/048244 Priority application(s): WO2007/048244

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006308405-Homogenization and heat-treatment of cast metals

2006308367-Running mechanism for a passenger boarding bridge and control method thereof